Table 2. Molecular features of patients with microdeletion encompassing the 2q23.1 region.
Patient 1 This study |
Patient 2 This study |
Patient 3 Vissers et al., 2003 Koolen et al., 2004 |
Patient 4 De Vries et al., 2005 |
Patient 5 De Gregori et al., 2007 |
|
---|---|---|---|---|---|
Deleted region | 2q23.1 | 2q22.3-q23.1 | 2q22.3-q23.2 | 2q23.1-q23.2 | 2q22.3-q23.1 |
Array method | Oligo-array, Agilent 4×44K | BAC-array, 3172 clones | BAC array, 3569 clones | BAC-array, 32 447 clones | Oligo-array, Agilent 244 K |
Breakpoints of imbalance | |||||
-region of proximal breakpoint | RP11-379G6/RP11-548K13 | RP11-67J2/RP11-89L3 | |||
148.836–149.062 | 145.268–146.891 | 145.410–146.734 | 149.17 (start clone) | 148.14–148.18 | |
-region of distal breakpoint | RP11-659J19/RP11-62P16 | RP11-72H23/RP11-79A11 | |||
149.319–149.362 | 149.268–150.720 | 148.694–151.147 | 150.09 (end clone) | 149.32–149.33 | |
Deletion minimal size (kb) | ~250 | ~2 400 | ~2 000 | ~920 | ~1 100 |
Candidate genes | ACVR2A | ACVR2A | ACVR2A | ||
ORC4L | ORC4L | ORC4L | |||
MBD5 | MBD5 | MBD5 | MBD5 | MBD5 | |
EPC2 | EPC2 | EPC2 | EPC2 | EPC2 | |
KIF5C | KIF5C |